Stoke Therapeutics (STOK) Return on Capital Employed: 2022-2025
Historic Return on Capital Employed for Stoke Therapeutics (STOK) over the last 3 years, with Sep 2025 value amounting to 0.08%.
- Stoke Therapeutics' Return on Capital Employed rose 55.00% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 55.00%. This contributed to the annual value of -0.48% for FY2024, which is 6.00% up from last year.
- As of Q3 2025, Stoke Therapeutics' Return on Capital Employed stood at 0.08%, which was down 27.11% from 0.11% recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Return on Capital Employed ranged from a high of 0.13% in Q1 2025 and a low of -0.65% during Q1 2024.
- Its 3-year average for Return on Capital Employed is -0.34%, with a median of -0.45% in 2023.
- Its Return on Capital Employed has fluctuated over the past 5 years, first decreased by 21bps in 2024, then surged by 78bps in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Return on Capital Employed stood at -0.44% in 2022, then decreased by 12bps to -0.56% in 2023, then climbed by 15bps to -0.42% in 2024, then soared by 55bps to 0.08% in 2025.
- Its Return on Capital Employed was 0.08% in Q3 2025, compared to 0.11% in Q2 2025 and 0.13% in Q1 2025.